Filing Details
- Accession Number:
- 0001127602-13-031483
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-13 16:25:19
- Reporting Period:
- 2013-11-12
- Filing Date:
- 2013-11-13
- Accepted Time:
- 2013-11-13 16:25:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1485939 | B George Abercrombie | Po Box 16069 Chapel Hill NC 27516 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-12 | 3,000 | $6.19 | 6,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.18 to $6.19, inclusive. The reporting person undertakes to provide to BioCryst Pharmaceuticals, Inc., any security holder of BioCryst Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
